This journal suppl. entitled: 2015 Gastrointestinal Symposium AbstractsGeneral Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract: abstract no. 286BACKGROUND: Molecular profiling data of GBC is scant and it is often included with other biliary cancers for analysis, which may hinder advancing drug discovery. METHODS: Archival formalin fixed paraffin embedded (FFPE) tissue of GBC from 2 research hospitals in Toronto (n=21) and Hong Kong (n=21) were analyzed by MassARRAY Sequenom panel (23 genes, 279 mutations), or by next general sequencing (NGS) using Proton or Illumina MiSeq TruSeq Amplicon Cancer Panel (48 genes, 212 amplicons, ≥500x coverage). Results of other biliary cancer and ampullary cancer from an ongoin...
Due to the fast progression in molecular technologies such as next-generation sequencing, knowledge ...
Item does not contain fulltextPURPOSE: Neuroendocrine carcinomas and mixed neuroendocrine non-neuroe...
Background: Cholangiocarcinoma (CCA) is clinically heterogeneous; intra and extrahepatic CCA have di...
Abstract Background The genetics of advanced biliary tract cancers (BTC), which encompass intra- and...
Background and aimsGallbladder carcinoma is a rare, aggressive malignancy of the biliary tract assoc...
Remarkable advancements in techniques of genomic profiling and bioinformatics have led to the accumu...
Background & Aims: Biliary tract cancers (BTCs) are clinically and pathologically heterogeneous ...
Cancer cell lines allow the identification of clinically relevant alterations and the prediction of ...
Biliary tract carcinoma (BTC) comprises gallbladder and intra-/extrahepatic cholangiocarcinoma (GBC,...
Noor-ul-Ain Tariq,1,2 Mairéad G McNamara,1,2 Juan W Valle1,2 1Faculty of Biomedicine and Heal...
Prognostic markers for cancer can assist in the evaluation of survival probability of patients and h...
Background: The genetics of advanced biliary tract cancers (BTC), which encompass intra- and extra-h...
AbstractBackground: Biliary tract cancers (BTCs) are rare and heterogeneous group of tumors classifi...
Purpose. Tumor metastasis remains the leading cause of cancer-related mortality in biliary tract can...
Biliary tract cancers (BTCs) are clinically and pathologically heterogeneous with poor response to t...
Due to the fast progression in molecular technologies such as next-generation sequencing, knowledge ...
Item does not contain fulltextPURPOSE: Neuroendocrine carcinomas and mixed neuroendocrine non-neuroe...
Background: Cholangiocarcinoma (CCA) is clinically heterogeneous; intra and extrahepatic CCA have di...
Abstract Background The genetics of advanced biliary tract cancers (BTC), which encompass intra- and...
Background and aimsGallbladder carcinoma is a rare, aggressive malignancy of the biliary tract assoc...
Remarkable advancements in techniques of genomic profiling and bioinformatics have led to the accumu...
Background & Aims: Biliary tract cancers (BTCs) are clinically and pathologically heterogeneous ...
Cancer cell lines allow the identification of clinically relevant alterations and the prediction of ...
Biliary tract carcinoma (BTC) comprises gallbladder and intra-/extrahepatic cholangiocarcinoma (GBC,...
Noor-ul-Ain Tariq,1,2 Mairéad G McNamara,1,2 Juan W Valle1,2 1Faculty of Biomedicine and Heal...
Prognostic markers for cancer can assist in the evaluation of survival probability of patients and h...
Background: The genetics of advanced biliary tract cancers (BTC), which encompass intra- and extra-h...
AbstractBackground: Biliary tract cancers (BTCs) are rare and heterogeneous group of tumors classifi...
Purpose. Tumor metastasis remains the leading cause of cancer-related mortality in biliary tract can...
Biliary tract cancers (BTCs) are clinically and pathologically heterogeneous with poor response to t...
Due to the fast progression in molecular technologies such as next-generation sequencing, knowledge ...
Item does not contain fulltextPURPOSE: Neuroendocrine carcinomas and mixed neuroendocrine non-neuroe...
Background: Cholangiocarcinoma (CCA) is clinically heterogeneous; intra and extrahepatic CCA have di...